J
Judith Bruchfeld
Researcher at Karolinska University Hospital
Publications - 109
Citations - 4561
Judith Bruchfeld is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 30, co-authored 88 publications receiving 3495 citations. Previous affiliations of Judith Bruchfeld include Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Towards tuberculosis elimination: an action framework for low-incidence countries
Knut Lönnroth,Giovanni Battista Migliori,Ibrahim Abubakar,Lia D'Ambrosio,Gerard De Vries,Roland Diel,Paul Douglas,Dennis Falzon,Marc Andre Gaudreau,Delia Goletti,Edilberto R. González Ochoa,Philip A. LoBue,Alberto Matteelli,Howard Njoo,Ivan Solovic,Alistair Story,Tamara Tayeb,Marieke J. van der Werf,Diana Weil,Jean-Pierre Zellweger,Mohamed Abdel Aziz,Mohamed R.M. Al Lawati,Stefano Aliberti,Wouter Arrazola de Oñate,Draurio Barreira,Vineet Bhatia,Francesco Blasi,Amy Bloom,Judith Bruchfeld,Francesco Castelli,Rosella Centis,Daniel Chemtob,Daniela Maria Cirillo,Alberto Colorado,Andrei Dadu,Ulf R Dahle,Laura De Paoli,Hannah Monica Yesudian Dias,Raquel Duarte,Lanfranco Fattorini,Mina Gaga,Haileyesus Getahun,Philippe Glaziou,Lasha Goguadze,Mirtha del Granado,Walter Haas,Asko Järvinen,Geun Yong Kwon,Davide Mosca,Payam Nahid,Nobuyuki Nishikiori,I. Noguer,Joan O'Donnell,Analita Pace-Asciak,Maria Grazia Pompa,Gilda Popescu,Carlos Robalo Cordeiro,Karin Rønning,Morten Ruhwald,Jean-Paul Sculier,Aleksandar Simunovic,Alison Smith-Palmer,Giovanni Sotgiu,Giorgia Sulis,Carlos A. Torres-Duque,Kazunori Umeki,Mukund Uplekar,Catharina Van Weezenbeek,Tuula Vasankari,Robert J. Vitillo,Constantia Voniatis,Maryse Wanlin,Mario C. Raviglione +72 more
TL;DR: An action framework for countries with low tuberculosis (TB) incidence sets out priority interventions required for these countries to progress first towards “pre-elimination” and eventually the elimination of TB as a public health problem.
Journal ArticleDOI
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Haileyesus Getahun,Alberto Matteelli,Ibrahim Abubakar,Mohamed Abdel Aziz,Annabel Baddeley,Draurio Barreira,Saskia Den Boon,Susana Marta Borroto Gutierrez,Judith Bruchfeld,Erlina Burhan,Solange Cavalcante,Rolando Cedillos,Richard E. Chaisson,Cynthia B.E. Chee,Lucy Chesire,Elizabeth L. Corbett,Masoud Dara,Justin T Denholm,Gerard De Vries,Dennis Falzon,Nathan Ford,Margaret Gale-Rowe,Chris Gilpin,Enrico Girardi,Un Yeong Go,Darshini Govindasamy,Alison D. Grant,Malgorzata Grzemska,Ross J Harris,C. Robert Horsburgh,Asker Ismayilov,Ernesto Jaramillo,Sandra V. Kik,Katharina Kranzer,Christian Lienhardt,Philip A. LoBue,Knut Lönnroth,Guy B. Marks,Dick Menzies,Giovanni Battista Migliori,Davide Mosca,Ya Diul Mukadi,Alwyn Mwinga,Lisa J. Nelson,Nobuyuki Nishikiori,Anouk M. Oordt-Speets,Molebogeng Xheedha Rangaka,Andreas Reis,Lisa D. Rotz,Andreas Sandgren,Monica Sañé Schepisi,Holger J. Schünemann,Surender Kumar Sharma,Giovanni Sotgiu,Helen R. Stagg,Timothy R. Sterling,Tamara Tayeb,Mukund Uplekar,Marieke J. van der Werf,Wim Vandevelde,Femke van Kessel,Anna H. van’t Hoog,Jay K. Varma,Natalia Vezhnina,Constantia Voniatis,Marije Vonk Noordegraaf-Schouten,Diana Weil,Karin Weyer,Robert J. Wilkinson,Takashi Yoshiyama,Jean-Pierre Zellweger,Mario C. Raviglione +71 more
TL;DR: The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation and patients with silicosis.
Journal ArticleDOI
Long-term consequences of COVID-19: research needs.
Dana Yelin,Eytan Wirtheim,Pauline Vetter,Andre C. Kalil,Judith Bruchfeld,Michael Runold,Giovanni Guaraldi,Cristina Mussini,Carlota Gudiol,Miquel Pujol,Alessandra Bandera,Luigia Scudeller,Mical Paul,Laurent Kaiser,Leonard Leibovici,Leonard Leibovici +15 more
Journal ArticleDOI
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Sergey Borisov,Keertan Dheda,Martin Enwerem,Rodolfo Romero Leyet,Lia D'Ambrosio,Rosella Centis,Giovanni Sotgiu,Simon Tiberi,Simon Tiberi,Jan-Willem C. Alffenaar,Andrey Maryandyshev,Evgeny Belilovski,Shashank Ganatra,Alena Skrahina,Onno W. Akkerman,Alena Aleksa,Rohit Amale,Janina Artsukevich,Judith Bruchfeld,Jose A. Caminero,Isabel Carpena Martinez,Luigi Codecasa,Margareth Pretti Dalcolmo,Justin T Denholm,Paul Douglas,Raquel Duarte,Aliasgar Esmail,Mohammed Fadul,Alexey Filippov,Lina Davies Forsman,Mina Gaga,Julia Amaranta Garcia-Fuertes,José-María García-García,Gina Gualano,Jerker Jonsson,Heinke Kunst,Jillian S.Y. Lau,Barbara Lazaro Mastrapa,Jorge Lazaro Teran Troya,Selene Manga,Katerina Manika,Pablo González Montaner,Jai B Mullerpattan,Suzette Oelofse,Martina Ortelli,Domingo Palmero,Fabrizio Palmieri,Antonella Papalia,Apostolos Papavasileiou,Marie-Christine Payen,Emanuele Pontali,Carlos Robalo Cordeiro,Laura Saderi,Tsetan Dorji Sadutshang,Tatsiana Sanukevich,Varvara Solodovnikova,Antonio Spanevello,Sonam Topgyal,Federica Toscanini,Adrian R Tramontana,Zarir F Udwadia,Pietro Viggiani,Veronica White,Alimuddin Zumla,Giovanni Battista Migliori +64 more
TL;DR: Bedaquiline-containing regimens achieved high conversion and success rates under different nonexperimental conditions, and is safe and effective in treating MDR- and XDR-TB patients.
Journal ArticleDOI
Tuberculosis and HIV Coinfection
TL;DR: The clinical management of HIV-associated TB includes the integration of effective anti-TB treatment, use of concurrent antiretroviral therapy (ART), prevention of HIV -related comorbidities, management of drug cytotoxicity, and prevention/treatment of immune reconstitution inflammatory syndrome (IRIS).